CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, received a notice from the NYSE MKT that the NYSE-MKT ...

(RTTNews.com) - CorMedix Inc. ( CRMD ) has been granted further extension time until June 30, 2013 to regain compliance with certain continued listing standards of the NYSE-MKT.